特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ゲノミクス市場:成長、動向、予測(2020~2025)

Genomics Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 925560
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
ゲノミクス市場:成長、動向、予測(2020~2025) Genomics Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年02月01日 ページ情報: 英文 120 Pages
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
概要

ゲノミクス市場は、予測期間中に9.3%のCAGRで成長すると予想されました。ゲノミクス市場の主な成長要因は、政府の支援の増加とゲノミクス研究の数の増加、シーケンスコストの低下、ゲノミクスの用途の増加です。ゲノミクス市場における指数関数的成長は、本質的な遺伝子開発の結果によるものです。また、エピスタシス、ヘテロシス、多面遺伝、および対立遺伝子と遺伝子座の間のゲノム内の他の関連などの多くの研究分野での用途も成長要因となります。そして、ゲノミクス市場を次の次元に引き上げる上で重要な役割を果たすものには他にもいくつかの要因があります。その中には、ゲノミクス市場の成長させること期待されるオンバイオエンジニアリングおよび合成生物学における用途があります。

当レポートでは、ゲノミスク市場を調査し、市場概要、市場の成長要因および阻害要因の分析、製品、サービス別・技術別・要点別・エンドユーザー別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概要
  • 市場成長要因
    • ゲノミクスのアプリケーション分野の拡大と政府資金の増加
    • シーケンスコストの低下
  • 市場の抑制要因
    • 設備費の高さ
  • ポーターのファイブフォース分析

第5章 市場細分化

  • 製品およびサービス別
    • 消耗品
    • システムとソフトウェア
    • サービス
  • 技術別
    • PCR
    • シーケンス
    • マイクロアレイ
    • 核酸の抽出と精製
    • その他
  • 用途別
    • 診断
    • 創薬と開発
    • 精密医学
    • その他
  • エンドユーザー別
    • 病院とクリニック
    • 研究センター
    • 製薬およびバイオテクノロジー企業
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Illumina, Inc.
    • Thermo Fisher Scientific
    • Agilent Technologies
    • Luminex Corporation
    • Myriad Genetics, Inc.
    • Perkinelmer Inc.
    • GE Healthcare
    • F. Hoffmann-La Roche Ltd.
    • Pacific Biosciences of California, Inc.
    • QIAGEN

第7章 市場機会および将来動向

目次
Product Code: 67971

The Genomics market studied was anticipated to grow with a CAGR of 9.3%, during the forecast period. The major factors attributing to the growth of the genomics market are growing government support and increased number of genomics studies, declining sequencing cost, increased genomics applications. The genomics market is geared to exponential growth as a result of the essential genetic developments and also because of its applications in numerous areas of study, such as intragenomic phenomena like epistasis, heterosis, pleiotropy, and other associations within the genome between alleles and loci. And there are few more factors which are playing crucial roles in taking the genomics market to the next level, among them one is on-bioengineering and synthetic biology applications which are expected to further propel the growth of the genomics market.

Key Market Trends

Consumables Segment is Expected to Hold the Largest Market Share in the Genomics Market

  • Genomics is widely used in medical, biotechnology, agriculture, diagnostics, and DNA Sequencing. Genomics is used in the healthcare sector to build vaccines and medicines. The use of consumables while making vaccines and drugs and in their testing have great applications.
  • According to the U.S. National Center for Biotechnology Data, oncology expenditure (research and treatment of tumors) is projected to increase by 7 percent - 10 percent yearly through 2020, with universal oncology costs approaching $150 billion. The use of genomics in making possible biomarkers for cancers and in the exploration of cell-free circulating DNA by several R&D sectors is upsurging the market growth.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall genomics market, throughout the forecast period. This is owing to the factors such as the rising incidence of chronic diseases such as cancer, increasing government entities investment in research, raising awareness of patients, and the availability of advanced healthcare infrastructure has contributed to growing technological advances in this sector and rising demand for biotechnological practices in the region, is anticipated to further drive the growth in this region. Further, the domicile presence of some of the major players in the region is also ensuring the dominance of the region.

Competitive Landscape

The genomics market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Illumina, Inc., Thermo Fisher Scientific, Agilent Technologies, Luminex Corporation, and Myriad Genetics, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Application area of Genomics and Increasing Government Funding
    • 4.2.2 Declining Sequencing Cost
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Equipment
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product & Services
    • 5.1.1 Consumables
    • 5.1.2 Systems & Software
    • 5.1.3 Services
  • 5.2 By Techniques
    • 5.2.1 PCR
    • 5.2.2 Sequencing
    • 5.2.3 Microarray
    • 5.2.4 Nucleic Acid Extraction and Purification
    • 5.2.5 Others
  • 5.3 By Application
    • 5.3.1 Diagnostics
    • 5.3.2 Drug Discovery and Development
    • 5.3.3 Precision Medicine
    • 5.3.4 Others
  • 5.4 By End User
    • 5.4.1 Hospitals & Clinics
    • 5.4.2 Research Centers
    • 5.4.3 Pharmaceutical and Biotechnology Companies
    • 5.4.4 Others
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Illumina, Inc.
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 Agilent Technologies
    • 6.1.4 Luminex Corporation
    • 6.1.5 Myriad Genetics, Inc.
    • 6.1.6 Perkinelmer Inc.
    • 6.1.7 GE Healthcare
    • 6.1.8 F. Hoffmann-La Roche Ltd.
    • 6.1.9 Pacific Biosciences of California, Inc.
    • 6.1.10 QIAGEN

7 MARKET OPPORTUNITIES AND FUTURE TRENDS